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Abstract 
Background and aims: Non-alcoholic fatty liver disease (NAFLD) and serum 25-
hydroxyvitamin D (s25(OH)D) concentrations are both associated with adiposity and insulin 
resistance (IR) and thus may be pathogenically linked. We aimed to determine the prevalence 
of vitamin D deficiency in adolescents with NAFLD and to investigate the longitudinal and 
cross-sectional associations between s25(OH)D concentrations and NAFLD.  
Methods: Participants in the population-based West Australian Pregnancy (Raine) Cohort 
had seasonally-adjusted s25(OH)D concentrations determined at ages 14 and then 17 years. 
NAFLD was diagnosed at 17 years using liver ultrasonography. Associations were examined 
after adjusting for potential confounders. Odds ratios (OR) and confidence intervals (CI) are 
reported per standard deviation in s25(OH)D concentrations. 
Results: NAFLD was present in 16% (156/994) of adolescents. The majority of participants 
with NAFLD had either insufficient (51%) or deficient (17%) vitamin D status. Lower 
s25(OH)D concentrations at 17 years were significantly associated with increased risk of 
NAFLD (OR 0.74, 95%CI 0.56,0.97; p=0.029), after adjusting for sex, race, physical activity, 
television/computer viewing, body mass index and IR. The effect of s25(OH)D 
concentrations at 17 years was minimally affected after further adjusting for s25(OH)D 
concentrations at 14 years (OR 0.76, 95%CI 0.56,1.03; p=0.072).  
Conclusions: Lower s25(OH)D concentrations are significantly associated with NAFLD, 
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NAFLD is appropriate, and clinical trials investigating the effect of vitamin D 
supplementation in the prevention and treatment of NAFLD may be warranted.  






Non-alcoholic fatty liver disease (NAFLD) is a pathological condition marked by excessive 
hepatic steatosis and may be associated with liver injury and progression to cirrhosis in some 
individuals
1
. Insulin resistance (IR) is considered a primary mechanism in the development of 
hepatic steatosis and well-documented risk factors for NAFLD include obesity, 
hyperlipidaemia, IR and type 2 diabetes mellitus
2
. In developed countries, NAFLD has been 
reported in approximately 20-35% of adults in the general population, increasing to 70-90% 
in obese individuals
6
. The prevalence of fatty liver in obese children in China, Italy, Japan, 








 and a 
growing body of evidence suggests that low serum 25-hydroxyvitamin D (s25(OH)D) 
concentrations are associated with IR, type 2 diabetes mellitus, cardiovascular disease and the 
metabolic syndrome
14
. Vitamin D receptors (VDR) regulate over 200 genes, including those 
involved in glucose and lipid metabolism
15
 and are widely distributed throughout the liver 
where they regulate hepatic lipid metabolism
16
. The hydroxylated form of 25(OH)D (1,25-
dihydroxyvitamin D) is capable of reducing free fatty acid-induced IR in peripheral tissues
17
. 
Furthermore, clinical trials have shown that vitamin D supplementation improves IR and 
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Although a number of studies have examined the relationship between vitamin D levels and 
NAFLD
19-25
, not all have included adequate adjustment for key potential confounders, such 
as adiposity, IR and physical activity. Furthermore, some studies have relied on alanine 
aminotransferase (ALT) as a biomarker for NAFLD, which is relatively insensitive and 
nonspecific for NAFLD
26, 27
. Most studies have been conducted in adult populations and, to 
our knowledge, only one study has examined the association between s25(OH)D 
concentrations and NAFLD in adolescents
21
. In order to elucidate the relationship between 
vitamin D levels and NAFLD in adolescents, we examined s25(OH)D concentrations at 14 
and 17 years and the presence of NAFLD identified by liver ultrasonography at 17 years, in a 






The Western Australian Pregnancy Cohort (Raine) Study is a prospective, population-based, 
study 
28
. In brief, a total of 2900 pregnant women from the public antenatal clinic at King 
Edward Memorial Hospital or surrounding private clinics in Perth, Western Australia, were 
recruited between May 1989 and November 1991, and gave birth to 2868 live children. These 
children underwent serial assessment at birth and throughout childhood and adolescence.  
Recruitment and all follow-ups were approved by the human research ethics committees of 
King Edward Memorial Hospital for Women and the Princess Margaret Hospital for 
Children, Perth, Western Australia. Informed and written consent was obtained from the 
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Assessment of NAFLD 
 
Liver ultrasonography was performed at the 17 year follow-up by trained ultrasonographers 
with a Siemens Antares ultrasound machine with a CH 6-2 curved array probe (Sequoia, 
Siemens Medical Solutions, Mountain View, CA) according to standardised protocol
30
 which 
provides 92% sensitivity and 100% specificity for the histological diagnosis of fatty liver. 
Ultrasound images were interpreted by a single specialist radiologist, who was blinded to the 
clinical and laboratory characteristics of the participants. Scores of 0-3, 0-2 and 0-1 were 
determined from captured images for liver echotexture, deep attenuation and vessel blurring, 
respectively. The diagnosis of fatty liver required a total score of two or more, including an 
echotexture score of one or more. The intra-observer reliability (κ statistic) for fatty liver 
diagnosis in this cohort was previously reported as 0.78 (95% CI 0.73,0.88)
31
. Hepatic fatty 
infiltration (steatosis) severity was classified by the total fatty liver score as 0 to 1 (no fatty 
liver), 2 to 3 (mild fatty liver), or 4 to 6 (moderate to severe fatty liver). 
 
Information on alcohol intake over the past 12 months was derived from a self-reported food 
frequency questionnaire developed by the CSIRO, Adelaide, Australia
32
. Based on diagnostic 
guidelines for NAFLD, adolescents with sonographic fatty liver were classified as having 
NAFLD if their self-reported weekly alcohol intake was less than 210 g and 140 g for males 
and females, respectively
6
. Medications and a comprehensive medical history were 
documented to exclude secondary causes of NAFLD and concomitant liver disease. 
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Venous blood samples were taken from an antecubital vein after an overnight fast and stored 
at -80°C until analysis. Serum 25(OH)D is extremely stable in storage, providing useful and 
accurate samples even in long term epidemiologic studies
33
. s25(OH)D concentrations at 14 
years were measured by enzyme immunoassay (Immunodiagnostic Systems Ltd, Scottsdale, 
Arizona, USA). At 17 years s25(OH)D2 and s25(OH)D3 concentrations were measured using 
isotope-dilution liquid chromatography-tandem mass spectrometry (LC-MS/MS) (RDDT, 
Victoria, Australia). Twelve samples from the 14 year cohort were also measured by LC-
MS/MS (RDDT, Victoria, Australia), according to published methodology
34
. Correlation 
between the enzyme immunoassay and LC-MS/MS was strong (r
2
=0.933), confirming that 
there were no vitamin D metabolites interfering with the immunoassay
35
. The inter-assay 
coefficients of variations (CVs) for the enzyme immunoassay were: low standard (40.3 
nmol/L) 4.6%; medium standard (72.0 nmol/L) 6.4%; high standard (132.0 nmol/L) 8.7%. 
For the LC-MS/MS, the CVs for s25(OH)D3 were: low standard (27.1 nmol/L) 7.1%; 
medium standard (75.4 nmol/) 5.0%; high standard (163.8 nmol/L) 5.3%. The CVs for 
s25(OH)D2 were: low standard (23.4 nmol/L) 8.8%; medium standard (66.0 nmol/) 6.7%; 
high standard (150.1 nmol/L) 6.7%. 
 
Since the immunoassay at the 14 year follow-up did not differentiate between s25(OH)D2 and 
25(OH)D3, analyses at both time points were performed on total s25(OH)D concentrations. A 
sinusoidal model incorporating month of blood collection was used to calculate 
deseasonalised s25(OH)D concentrations
36
. Vitamin D status was defined as sufficient when 
concentrations of s25(OH)D were ≥75 nmol/L, insufficient when they were 50-74.9 nmol/L 
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Laboratory assessments at the 17 year follow-up were performed with venous blood samples 
taken from an antecubital vein after an overnight fast and stored at -80°C. Serum glucose, 
insulin, triglyceride, total cholesterol, high-density lipoprotein cholesterol (HDL-C), ALT 
and gamma-glutamyl transpeptidase (GGT) were assayed. All assays were performed at an 
accredited central laboratory (PathWest Laboratories, Perth, Western Australia). The 
homeostatic model assessment for IR (HOMA-IR) score was calculated as follows: HOMA-




Potential confounding variables 
 
Participants were classified as Caucasian if both parents were Caucasian, or as non-Caucasian 
if one or both parents were of an alternate ethnicity. Participants were weighed to the nearest 
100 g using a Wedderburn Digital Chair Scale and height was determined to the nearest 0.1 
cm with a Holtain Stadiometer. BMI (kg/m
2
) at 17 years was categorised using sex- and age-
specific thresholds recommended by the International Obesity Task Force 
39, 40
. Waist 
circumference was measured at the level of the umbilicus to the nearest 0.1 cm until two 
readings were within one centimetre of each other. Central obesity was defined as waist 
circumference ≥80 cm in females and ≥94 cm in males, consistent with International Diabetes 
Federation criteria
41
. Suprailiac skinfold measurements were obtained with a skinfold caliper 
(Holtain Tanner/Whitehouse skinfold caliper, Holtain, Crosswell, United Kingdom). Physical 
activity at 17 years was assessed using a self-reported questionnaire based on exercise outside 
of school hours per week, with exercise defined in three categories as activity causing 
breathlessness or sweating (≥4 times per week, 1-3 times per week and <once per week). 
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based on the number of hours per day spent watching television or videos, or using the 




Analyses were performed using IBM SPSS Statistics Release Version 19.9.9.1 (IBM SPSS 
Inc., 2010, Chicago, IL). Statistical significance was defined as two-tailed p<0.05. Baseline 
characteristics of participants and presence of NAFLD at 17 years were compared using 
Pearson’s chi-square tests for categorical variables, independent samples t-tests for 
parametric continuous variables and Mann-Whitney U tests for non-parametric continuous 
variables. The correlation between s25(OH)D concentrations at 14 and 17 years was 
examined using Pearson Correlation. 
 
Odds ratios (OR), confidence intervals (CI) and β coefficients are reported per standard 
deviation of deseasonalised s25(OH)D concentrations, with the standard deviation based on 
the sample of 718 adolescents. We examined univariate associations between s25(OH)D 
concentrations at both 14 and 17 years and NAFLD at 17 years. Multiple logistic regression 
was applied to investigate associations between s25(OH)D concentrations at both 14 and 17 
years and NAFLD at 17 years. Models were first adjusted for sex, race, physical activity and 
television/computer viewing. The model fit was similar using three measures of adiposity 
(BMI, waist circumference and suprailiac skinfold). Since more complete data were available 
for BMI, we used this measure of adiposity in the analyses. Models were then further 
adjusted for BMI and HOMA-IR. We investigated interactions between sex, BMI, physical 
activity and s25(OH)D concentrations. We also combined serum 25OHD concentrations from 
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s25(OH)D concentrations at 17 years as a binary variable for vitamin D 
insufficiency/deficiency (<75 nmol/L) and sufficiency (≥75 nmol/L), adjusted as above. 
 
The association between s25(OH)D concentrations and severity of hepatic steatosis was 
explored using one-way ANOVA. We examined univariate associations between s25(OH)D 
concentrations at both 14 and 17 years and aminotransaminases (ALT and GGT) at 17 years. 
Multivariate general linear models were used to investigate associations between s25(OH)D 
concentrations at 17 years and aminotransaminases at 17 years, adjusted first for sex, race, 





Characteristics of study participants and presence of NAFLD 
 
Participants in the current study were more likely to be Caucasian, from families with a 
higher income during pregnancy, and from mothers with a higher age at birth, higher 
education and healthier body mass index (Supplementary Table 1). A total of 1754 
adolescents participated in the 17 year follow-up between July 2006 and June 2009 
(Supplementary Figure 1). Data on both s25(OH)D concentrations at 17 years and liver 
ultrasonography at 17 years were available for 994 participants. Complete data, including 
s25(OH)D concentrations at 14 and 17 years, and all confounding variables, were available 
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A total of 156/994 participants (16%) were identified by liver ultrasonography and self-
reported alcohol intake as having NAFLD at 17 years. Of those identified with NAFLD, 62% 
were female and 39% were male (p<0.001) (Table 1). Central obesity, as determined by waist 
circumference, was also significantly more prevalent in females compared to males (38% v 
12%, p<0.001, data not shown). As expected, participants with NAFLD, compared to those 
without NAFLD, had higher measures of adiposity (BMI, waist circumference, suprailiac 
skinfold), dyslipidemia (serum fasting triglyceride, HDL-cholesterol), insulin resistance 
(serum insulin, HOMA-IR) and liver transaminases (ALT, GGT) (p<0.005 for all). Those 
with NAFLD were also less likely to be physically active compared to those without NAFLD 
(p=0.020).  
 
Serum 25(OH)D concentrations and NAFLD 
 
The prevalence of vitamin D deficiency and insufficiency at 17 years was higher in those 
with NAFLD compared to those without NAFLD (p<0.001) (Table 1). Of the participants 
who were vitamin D sufficient, 10% had NAFLD; in contrast, among those who were vitamin 
D deficient, 23% had NAFLD (Figure 1). Mean (± standard deviation) s25(OH)D 
concentrations at 17 years were significantly lower in those with NAFLD (67±22 nmol/L) 
compared to those without NAFLD (77±24 nmol/L, p<0.001). Similarly, s25(OH)D 
concentrations at 14 years were lower among individuals subsequently diagnosed with 
NAFLD at 17 years compared to those who had no NAFLD (80±23 nmol/L vs. 87±28 
nmol/L, p=0.005).  
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In univariate analyses, s25(OH)D concentrations at 14 years were significantly associated 
with NAFLD at 17 years (OR 0.68, 95% CI 0.54,0.86; p=0.001, data not shown). After 
adjusting for sex, race, physical activity and television/computer viewing at 17 years, 
s25(OH)D concentrations at 14 years were significantly associated with NAFLD at 17 years 
(OR 0.69, 95% CI 0.54,0.89; p=0.004) (Table 2). However, when further adjusted for 
HOMA-IR and BMI at 17 years, the association was attenuated. There were no significant 
interactions between sex, BMI or physical activity and s25(OH)D concentrations.  
 
Serum 25(OH)D concentrations at 17 years and risk of NAFLD at 17 years 
 
In univariate analyses, s25(OH)D concentrations at 17 years were significantly associated 
with NAFLD at 17 years (OR 0.61, 95% CI 0.49,0.76; p<0.001, data not shown). After 
adjusting for sex, race, physical activity and television/computer viewing, s25(OH)D 
concentrations at 17 years were significantly associated with NAFLD (OR 0.58, 95% CI 
0.45,0.73; p<0.001) (Table 3). When further adjusted for HOMA-IR and BMI, the significant 
association remained (OR 0.74, 95% CI 0.56,0.97; p=0.029). There were no significant 
interactions between sex, BMI or s25(OH)D concentrations. The correlation between 
s25(OH)D concentrations at 14 and 17 years was 0.50 (p<0.001). When s25(OH)D 
concentrations at 14 and 17 years were combined in one adjusted model, there was minimal 
change in the effect of s25(OH)D concentrations at 17 years and NAFLD (Table 4).  
 
The risk of NAFLD was nearly double for those with insufficient/deficient vitamin D status 
compared to those with sufficient status, after adjusting for sex, race, physical activity and 
television/computer viewing, BMI and HOMA-IR (OR 1.85, 95% CI 1.13,3.01; p=0.014) 
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the risk of NAFLD remained significantly higher in those with insufficient/deficient vitamin 
D status at 17 years compared to those who were sufficient in vitamin D (OR 1.76, 95% CI 
1.05,2.96; p=0.033). 
 
Serum 25(OH)D concentrations and sonographic severity of hepatic steatosis 
 
There was a significant difference (p < 0.001) in s25(OH)D concentrations between levels of 
hepatic steatosis, with s25(OH)D concentrations decreasing as sonographic severity of 
steatosis increased (n = 718). Mean (95% CI) s25(OH)D concentrations were 78 (76, 80) 
nmol/L for those with no fatty liver, 70 (65, 74) nmol/L in those with mild fatty liver, and 59 
(50, 69) nmol/L in those with moderate to severe fatty liver. 
 
Serum 25(OH)D concentrations and aminotransamination 
 
s25(OH)D concentrations at 14 years were not significantly associated with ALT or GGT at 
17 years in univariate analyses; however, s25(OH)D concentrations at 17 years were 
inversely associated with both ALT (β -1.24, 95% CI -2.18,-0.30; p=0.010) and GGT (β -
1.02, 95% CI -1.56,-0.48; p<0.001) at 17 years (n=718, data not shown). When adjusted for 
sex, race, physical activity and television/computer viewing, s25(OH)D concentrations at 17 
years remained associated with serum ALT levels but the association was non-significant 
when further adjusted for HOMA-IR and BMI (Supplementary Table 3). Similarly, 
s25(OH)D concentrations at 17 years were not significantly associated with serum GGT 
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To our knowledge, this is the first population-based study in adolescents investigating the 
relationship between s25(OH)D concentrations and NAFLD using liver ultrasonography. Our 
results suggest as association between s25(OH)D concentrations and NAFLD independent of 
adiposity, physical activity and IR. Furthermore, current s25(OH)D concentrations had a 
stronger effect on the risk of NAFLD than prior s25(OH)D concentrations. However, since 
s25(OH)D concentrations at 14 and 17 years are correlated, low vitamin levels at 14 years do 
have some predictive ability in identifying adolescents at risk of NAFLD at 17 years. 
 
A number of studies have found significant associations between vitamin D levels and 
NAFLD; however, these are mostly from specialised clinical centres. In 60 Italian adults, 
Targher and colleagues found that patients with biopsy-proven NAFLD had markedly lower 
s25(OH)D concentrations than matched controls 
23
. Furthermore, in a study of 262 Italian 
adults, patients with NAFLD had reduced s25(OH)D concentrations compared to subjects 
without NAFLD and the association was not affected by BMI
22
. Similarly, in a retrospective 
case-control study of 1214 adult outpatients in the United States, NAFLD was associated 




Several studies have shown no association between vitamin D levels and NAFLD. In a 
population-based cohort of adolescents in the United States (n=1630), s25(OH)D 
concentrations were not associated with suspected NAFLD, assessed by elevated ALT, after 
adjustment for obesity
21
. However, although serum ALT is commonly used in large-scale 
epidemiological studies as a biomarker for liver fat accumulation, it may not accurately 
represent NAFLD
26, 27
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with the presence of NAFLD as assessed by liver ultrasonography, s25(OH)D concentrations 
were not associated with ALT in adjusted models. 
 
There are a number of plausible explanations for the association between vitamin D 
deficiency and the development and progression of NAFLD. VDR are expressed throughout 
the liver where they regulate hepatic lipid metabolism, hepatic necroinflammation and 
fibrosis
16
. Hepatic expression of VDR is negatively associated with the severity of liver 
histology in patients with nonalcoholic steatohepatitis (NASH) or chronic hepatitis C, 
indicating that VDR may play a role in the progression of chronic liver damage
43
. There is 
also a strong association between low vitamin D levels and IR, which leads to hepatic 
steatosis
44, 45
. Vitamin D depletion increased insulin resistance and up-regulated hepatic 
inflammatory and oxidative stress genes, exacerbating NAFLD
46
. In our human cohort study, 
however, we found no association between vitamin D and IR independent of NAFLD and 
were not able to assess the association between vitamin D and hepatic inflammation given the 
lack of liver histology.  
 
It is possible that vitamin D may influence the development and progression of NAFLD in 
susceptible individuals with certain genetic polymorphisms. Genetic variations in vitamin D 
metabolism have been identified and may be associated with liver fibrosis
47
. In a genome-
wide association study conducted in the Raine cohort
48
 we observed that a common single 
nucleotide polymorphism (rs222054) in the group specific component gene (which encodes 
vitamin D binding protein) was associated with NAFLD. Furthermore, GC hepatic gene 
expression and serum protein levels were significantly altered in adult NAFLD subjects 
compared to controls, further suggesting that vitamin D metabolism was associated with a 
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Although participants included in the current study were more likely to be from families with 
higher socioeconomic status relative to participants from the original cohort, the original 
Raine cohort slightly over-represented socially disadvantaged families, leaving an active 
cohort that is more representative of the general Western Australian population
29
.A strength 
of this study included extensive characterization of a population-based cohort, allowing us to 
assess the impact of various confounding factors. However, although we adjusted for physical 
activity and sedentary activity, the measure of assessment was not based on a validated 
questionnaire and may be subject to self-reporting bias. Furthermore, our assessment of 
physical activity did not differentiate between indoor and outdoor activity.   
 
A further limitation of our study was the use of liver ultrasonography to detect the presence 
of NAFLD, rather than the gold-standard of liver biopsy. Liver ultrasonography becomes less 
sensitive when detecting low levels of steatosis, and only liver biopsy can determine disease 
severity. However, liver ultrasound provides a useful non-invasive estimate of histological 
hepatic steatosis in children and adults, and is recommended for assessment in large 
population-based studies
49
. Although this study included s25(OH)D concentrations at two 
time points, the assessment of NAFLD was only conducted at 17 years; therefore, we cannot 
infer causality in the relationship between s25(OH)D concentrations and NAFLD.  
 
Our results demonstrate that vitamin D insufficiency and deficiency are more common in 
adolescents with NAFLD than those without NALFD. The high prevalence of vitamin D 
insufficiency and deficiency in adolescents with NAFLD is concerning, since low vitamin D 
levels may contribute to other health problems beyond the risk of NAFLD. We found a 
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independent of adiposity and IR. Given that NAFLD is considered the hepatic manifestation 
of the metabolic syndrome, prospective studies addressing vitamin D status and the metabolic 
syndrome are warranted. Screening for vitamin D deficiency in adolescents at risk of 
NAFLD, and clinical trials investigating the effect of vitamin D supplementation in the 
prevention and treatment of NAFLD, may be appropriate. Further studies are needed to 
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Figure 1. Percentage of participants with and without NAFLD in relation to vitamin D 
status at 17 years (n=994) 
Vitamin D status: sufficient, 25(OH)D ≥75 nmol/L; insufficient, 25(OH)D 50-74.9 nmol/L; 
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Table 1. Characteristics of study participants and presence of NAFLD at 17 years 
(n=994) 
  No NAFLD   NAFLD   p value 
  n     n       
Sex
1
 838   156   <0.001* 
     Male  457 (55)   60 (38)   
     Female  381 (45)   96 (62)   
Race
1
 838   156   0.680 
     Caucasian  709 (85)   134 (86)   
     Non-Caucasian  129 (15)   22 (14)   
25(OH)D at 17 years (nmol/L)
3
 838 77 ± 24  156 67± 22  <0.001* 
Vitamin D status
1
 838   156    
     Sufficient  429 (51)   50 (32)  <0.001* 
     Insufficient  316 (38)   79 (51)   
     Deficient  93 (11)   27 (17)   
25(OH)D at 14 years (nmol/L)
3
 724 87± 28  137 80 ± 23  0.005* 
BMI (kg/m2)
2
 838 22 (20, 24)  155 27 (23, 33)  <0.001* 
BMI categories
1
 838   155   <0.001* 
     Underweight  58 (7)   6 (4)   
     Healthy weight  647 (77)   57 (37)   
     Overweight  104 (12)   37 (24)   
     Obese  29 (4)   55 (36)   
Waist circumference (cm)
2
 815 76 (72, 82)  144 87 (77, 102)  <0.001* 
Waist circumference IDF
1
 815   144   <0.001* 
    <IDF threshold  673 (83)   53 (37)   
     ≥IDF threshold  142 (17)   91 (63)   
Suprailiac skinfold (cm)
2
 801 12 (8, 18)  124 25 (17, 33)  <0.001* 
Total cholesterol (mmol/L)
3
 812 4.1 ± 0.7   154 4.2 ± 0.9  0.069 
HDL (mmol/L)
3
 812 1.3 ± 0.3    154 1.2 ± 0.3  0.001 
Triglycerides (mmol/L)
2
 812 0.9 (0.7, 1.2)  154 1.1 (0.8, 1.5)  <0.001* 
Glucose (mmol/L)
2
 811 4.7 (4.5, 5)  154 4.7 (4.5, 5)  0.252 
Insulin (mU/L)
2
 812 7.0 (4.7, 10.3)  154 9.8 (6.8, 15.9)  <0.001* 
HOMA-IR
2
 811 1.5 (1.0, 2.2)  154 2.1 (1.4, 3.3)  <0.001* 
ALT (IU/L)
3
 812 20 ± 10   154 27 ± 20  <0.001* 
GGT (IU/L)
3
 812 14 ± 20  154 18 ± 11  <0.001* 
Physical activity
1
 712   140   0.020* 
     ≥4 times per week  189 (27)   23 (16)   
     1-3 times per week  381 (54)   79 (56)   
    <once per week  142(20)   38 (27)   
Television/computer viewing
1
 893   161   0.347 
    <2 hours per day  223 (29)   34 (24)   
     2-4 hours per day  300 (40)   56 (40)   
     >4 hours per day   236 (31)     51 (36)     
NAFLD, non-alcoholic fatty liver disease; BMI, body mass index; IDF, International 
Diabetes Federation; 25(OH)D, deseasonalised 25-hydroxyvitamin D; HDL, high-density 











This article is protected by copyright. All rights reserved. 
aminotransferase; GGT, gamma-glutamyl transpeptidase; 
1
Chi square test (n (%)); 
2
Mann-
Whitney U test (median (IQR)); 
3
t-test (mean ± standard deviation); *Significant at the 
p<0.05 level 
















Table 2. Adjusted logistic regression models of deseasonalised s25(OH)D 1 
concentrations at 14 years and risk of NAFLD at 17 years (n=718) 2 
  Model 1
1
   Model 2
2
 
  OR (95% CI) 
p 
value  OR (95% CI) p value 
25(OH)D (per SD) at 14 years 0.69 (0.54, 0.89) 0.004*  0.84 (0.64, 1.09) 0.191 
Sex (female v male) 1.50 (0.98, 2.30) 0.059  1.75 (1.07, 2.86) 0.025* 
Race (non-Caucasian v Caucasian) 0.68 (0.37, 1.23) 0.198  1.20 (0.61, 2.34) 0.600 
Physical activity  0.105   0.112 
     ≥4 times per week -   -  
     1-3 times per week 1.71 (0.97, 2.99) 0.063  1.48 (0.78, 2.80) 0.230 
    <once per week 1.96 (1.02, 3.73) 0.042*  2.17 (1.04, 4.52) 0.038* 
Television/computer viewing  0.374   0.797 
    <2 hours per day -   -  
     2-4 hours per day 1.27 (0.77, 2.12) 0.350  1.19 (0.68, 2.10) 0.547 
     >4 hours per day 1.47 (0.86, 2.51) 0.163  1.20 (0.65, 2.21) 0.557 
HOMA-IR    1.04 (0.90, 1.19) 0.629 
BMI (kg/m
2
)       1.32 (1.24, 1.40) <0.001* 
 3 
25(OH)D, deseasonalised serum 25-hydroxyvitamin D concentrations; SD, standard 4 
deviation; HOMA-IR, homeostatic model assessment for insulin resistance; BMI, body 5 
mass index 6 
1
Adjusted for sex, race, physical activity and television/computer viewing at 17 years; 7 
2
Further adjusted for HOMA-IR and BMI at 17 years 8 















Table 3. Adjusted logistic regression models of deseasonalised s25(OH)D 12 
concentrations at 17 years and risk of NAFLD at 17 years (n=718) 13 
  Model 1
1
   Model 2
2
 
  OR (95% CI) p value  OR (95% CI) p value 
25(OH)D (per SD) at 17 years 0.58 (0.45, 0.73) <0.001*  0.74 (0.56, 0.97) 0.029* 
Sex (female v male) 1.81 (1.18, 2.78) 0.006*  1.89 (1.16, 3.09) 0.011* 
Race (non-Caucasian v Caucasian) 0.58 (0.31, 1.06) 0.077  1.08 (0.55, 2.13) 0.818 
Physical activity  0.196   0.172 
     ≥4 times per week -   -  
     1-3 times per week 1.67 (0.95, 2.93) 0.078  1.51 (0.80, 2.86) 0.209 
    <once per week 1.65 (0.85, 3.17) 0.137  2.03 (0.97, 4.24) 0.061 
Television/computer viewing  0.286   0.743 
    <2 hours per day -   -  
     2-4 hours per day 1.32 (0.79, 2.20) 0.289  1.21 (0.69, 2.14) 0.505 
     >4 hours per day 1.54 (0.90, 2.65) 0.116  1.24 (0.67, 2.29) 0.488 
HOMA-IR    1.03 (0.90, 1.19) 0.636 
BMI (kg/m
2
)       1.31 (1.23, 1.39) <0.001* 
 14 
25(OH)D, deseasonalised serum 25-hydroxyvitamin D concentrations; SD, standard 15 
deviation; HOMA-IR, homeostatic model assessment for insulin resistance; BMI, body 16 
mass index 17 
1
Adjusted for sex, race, physical activity and television/computer viewing at 17 years; 18 
2
Further adjusted for HOMA-IR and BMI at 17 years 19 















Table 4. Adjusted logistic regression model combining deseasonalised s25(OH)D 23 
concentrations at 14 and 17 years and risk of NAFLD at 17 years (n=718) 24 
  OR (95% CI) p value 
25(OH)D (per SD) at 17 years 0.76 (0.56, 1.03) 0.072 
25(OH)D (per SD) at 14 years 0.94 (0.70, 1.26) 0.685 
Sex (female v male) 1.86 (1.14, 3.06) 0.014* 
Race (non-Caucasian v Caucasian) 1.07 (0.54, 2.11) 0.855 
Physical activity  0.167 
     ≥4 times per week -  
     1-3 times per week 1.50 (0.79, 2.85) 0.211 
    <once per week 2.04 (0.98, 4.27) 0.059 
Television/computer viewing  0.763 
    <2 hours per day -  
     2-4 hours per day 1.20 (0.68, 2.13) 0.525 
     >4 hours per day 1.23 (0.67, 2.27) 0.509 
HOMA-IR 1.03 (0.89, 1.19) 0.650 
BMI (kg/m
2
) 1.31 (1.23, 1.39) <0.001* 
 25 
25(OH)D, deseasonalised serum 25-hydroxyvitamin D concentrations; SD, standard 26 
deviation; HOMA-IR, homeostatic model assessment for insulin resistance; BMI, body 27 
mass index 28 





























Supplementary Table 1. Characteristics of participants who provided a blood sample 
and underwent liver ultrasonography at the 17 year follow-up (n = 944) v non-
participants from the original cohort (n = 1874) 
  Participants   
Non-
participants   p 
  n (%)   n (%)     
Sex 
    
0.318 
     Male 517(52.0) 938 (50.1) 
      Female 477 (48.0) 
 
936 (49.9) 
 Race  
   
0.021* 










Family income per year during pregnancy 
    
< 0.001* 
     < $7,000 56 (5.6) 
 
173(9.2) 
       $7,000-$11,999 70 (7.0) 
 
173(9.2) 
       $12,000-$23,999 211 (21.2) 
 
472 (25.2) 
       $24,000-$35,999 243 (24.4) 
 
405(21.6) 
       ≥ $36,000 364 (36.6) 
 
471 (25.1) 
       Unknown  
 
 
  Maternal age at birth  
   
< 0.001* 
     < 20 years 55 (5.5) 
 
223(11.9) 
       20-24 years 178 (17.9) 
 
429 (22.9) 
       25-29 years 278 (28.0) 
 
576 (30.7) 
       30-34 years 306(30.8) 
 
420 (22.4) 
       35-39 years 141(14.2) 
 
159 (8.5) 
       ≥ 40 years 33 (3.3) 
 
30 (1.6) 
  Maternal education since school 
    
< 0.001* 
     None 424 (42.7) 
 
1024 (54.6) 
       Trade certificate or apprenticeship 73 (7.3) 
 
162 (8.6) 
       Professional registration (non-degree) 113(11.4) 
 
133 (7.1) 
       College diploma or degree 178 (17.9) 
 
270 (14.4) 
       University degree 133 (13.4) 
 
147 (7.8) 
       Other 55 (5.5) 
 
92 (4.9) 
  Maternal pre-pregnancy body mass index 
    
0.025* 
     Underweight (< 18.5) 101 (10.2) 
 
214 (11.4) 
       Healthy weight (18.5-24.9) 687(69.1) 
 
1207 (64.4) 
       Overweight (25-29.9) 109 (11.0) 
 
204 (10.9) 












Supplementary Table 2. Adjusted logistic regression models of serum 25(OH)D concentrations < 75 nmol/L v ≥ 75 nmol/L at 17 years and 
risk of NAFLD at 17 years (n = 718) 
  Model 1
1
   Model 2
2
   Model 3
3
 
  OR (95% CI) p value 
 
OR (95% CI) p value 
 
OR (95% CI) p value 
Vitamin D status (< 75 v ≥ 75 nmol/L) 2.41 (1.57, 3.71) <0.001* 
 
1.85 (1.13, 3.01) 0.014* 
 
1.76 (1.05, 2.96) 0.033* 
Sex (female v male) 1.74 (1.13, 2.66) 0.011* 
 
1.87 (1.14, 3.06) 0.013* 
 
1.85 (1.12, 3.03) 0.015* 
Race (non-Caucasian v Caucasian) 0.67 (0.37, 1.21) 0.180 
 
1.12 (0.58, 2.18) 0.734 
 













     1-3 times per week 1.70 (0.97, 3.00) 0.065 
 
1.54 (0.81, 2.94) 0.186 
 
1.54 (0.81, 2.93) 0.191 
     < once per week 1.74 (0.90, 3.35) 0.097 
 
2.06 (0.98, 4.32) 0.056 
 
2.07 (0.99, 4.33) 0.055 










     2-4 hours per day 1.34 (0.80, 2.23) 0.263
 
1.22 (0.69, 2.15) 0.497 
 
1.21 (0.68, 2.13) 0.520 
     > 4 hours per day 1.61 (0.94, 2.76) 0.085 
 
1.26 (0.68, 2.33) 0.460 
 
1.25 (0.67, 2.31) 0.483 
HOMA-IR 
   
1.04 (0.90, 1.19) 0.618 
 




   
1.31 (1.24, 1.40) <0.001* 
 
1.31 (1.24, 1.39) <0.001* 
25(OH)D (per 10 nmol/L) at 14 years             0.97 (0.88, 1.08) 0.613 
 
25(OH)D, deseasonalised serum 25-hydroxyvitamin D concentrations; HOMA-IR, homeostatic model assessment for insulin resistance; BMI, 
body mass index 
1
Adjusted for sex, race, physical activity and television/computer viewing at 17 years; 
2
Further adjusted for HOMA-IR and BMI at 17 years; 
3
Further adjusted for serum 25(OH)D concentrations at 14 years 











Supplementary Table 3. Adjusted general linear models of deseasonalised serum 
25(OH)D concentrations at 17 years and serum alanine aminotransferase at 17 years 
(n = 718) 
  Model 1
1
   Model 2
2
 
  β (95% CI) p value 
 
β (95% CI) p value 
25(OH)D (per SD) -1.18 (-2.13, -0.22) 0.016* 
 
-0.36 (-1.29, 0.57) 0.450 
Sex (female v male) -6.00 (-7.90, -4.09) <0.001* 
 
-6.45 (-8.27, -4.63) <0.001* 
Race (non-Caucasian v Caucasian) -1.40 (-4.08, 1.27) 0.303 
 
0.36 (-2.22, 2.94) 0.785 
Physical activity 
     




     1-3 times per week -0.54 (-2.80, 1.72) 0.640 
 
-0.81 (-2.95, 1.34) 0.462 
     < once per week 0.82 (-2.04, 3.67) 0.575 
 
1.38 (-1.34, 4.10) 0.319 
Television/computer viewing 
     




     2-4 hours per day -0.09 (-2.31, 2.13) 0.938 
 
-0.51 (-2.63, 1.61) 0.638 
     > 4 hours per day 0.32 (-2.08, 2.72) 0.794 
 
-0.44 (-2.73, 1.85) 0.707 
HOMA-IR 
   
0.14 (-0.21, 0.50) 0.427 
BMI (kg/m
2
)       0.90 (0.67, 1.12) <0.001* 
 
25(OH)D, deseasonalised serum 25-hydroxyvitamin D concentrations; SD, standard 
deviation; HOMA-IR, homeostatic model assessment for insulin resistance; BMI, body 
mass index 
1
Adjusted for sex, race, physical activity and television/computer viewing; 
2
Further 












Supplementary Table 4. Adjusted general linear models of deseasonalised serum 
25(OH)D concentrations at 17 years and serum gamma-glutamyl transpeptidase at 17 
years (n = 718) 
  Model 1
1
   Model 2
2
 
  β (95% CI) p value 
 
β (95% CI) p value 
25(OH)D (per SD) -0.70 (-1.25, -0.15) 0.012* 
 
-0.24 (-0.76, 0.29) 0.374 
Sex (male v female) -3.63 (-4.72, -2.54) <0.001* 
 
-3.96 (-4.98, -2.94) <0.001* 
Race (Caucasian v non-Caucasian) 1.94 (0.41, 3.47) 0.013 
 
2.76 (1.31, 4.21) <0.001* 
Physical activity 
     




     1-3 times per week 0.06 (-1.23, 1.35) 0.927 
 
-0.06 (-1.27, 1.15) 0.924 
     < once per week 1.61 (-0.03, 3.24) 0.054 
 
1.98 (0.45, 3.51) 0.011* 
Television/computer viewing 
     




     2-4 hours per day 0.21 (-1.06, 1.48) 0.746 
 
-0.10 (-1.29, 1.09) 0.869 
     > 4 hours per day -0.30 (-1.67, 1.08) 0.673 
 
-0.69 (-1.98, 0.60) 0.293 
HOMA-IR 
   
0.53 (0.33, 0.73) <0.001* 
BMI (kg/m
2
)       0.41 (0.28, 0.53) <0.001* 
 
 25(OH)D, deseasonalised serum 25-hydroxyvitamin D concentrations; SD, standard 
deviation; HOMA-IR, homeostatic model assessment for insulin resistance; BMI, body 
mass index 
1
Adjusted for sex, race, physical activity and television/computer viewing; 
2
Further 































Supplementary Figure 1. Flow diagram of adolescents attending the 17 year follow-up 
and those included in the final models 







1754 Attended 17 year follow-up 
 
1268 Provided a blood sample 
1170 Underwent liver ultrasonography 
 
Missing data: 
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29 HOMA-IR 
1 Body mass index 









718 Included in regression models 
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